Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Bennett Garnick, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Garnick MB, Einstein DJ. EDITORIAL COMMENT. Urology. 2020 Nov; 145:118-119. PMID: 33167168.
    Citations:    Fields:    
  2. Crawford ED, Andriole G, Freedland SJ, Garnick M, Gomella LG, Henderson J, Higano CT, Kader AK, Kane C, Keane TE, Koo PJ, Petrylak DP, Reiter RE, Slovin SF, Yu EY. Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. Can J Urol. 2020 10; 27(5):10352-10362. PMID: 33049187.
    Citations:    Fields:    
  3. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811. PMID: 32516092.
    Citations: 15     Fields:    Translation:Humans
  4. Garnick MB, Einstein DJ. EDITORIAL COMMENT. Urology. 2019 09; 131:182-183. PMID: 31451158.
    Citations:    Fields:    Translation:Humans
  5. Garnick MB. More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. N Engl J Med. 2019 05 16; 380(20):e38. PMID: 31091399.
    Citations:    Fields:    Translation:Humans
  6. Garnick MB. Filling in the Gaps. JAMA. 2018 May 22; 319(20):2079-2080. PMID: 29800185.
    Citations:    Fields:    Translation:Humans
  7. Crawford ED, Schally AV, Pinthus JH, Block NL, Rick FG, Garnick MB, Eckel RH, Keane TE, Shore ND, Dahdal DN, Beveridge TJR, Marshall DC. The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urol Oncol. 2017 05; 35(5):183-191. PMID: 28325650.
    Citations: 10     Fields:    Translation:HumansAnimals
  8. Garnick MB, Balter W. Rethinking the use of physicians as hired expert lecturers. Ann Intern Med. 2015 Feb 17; 162(4):320-1. PMID: 25686175.
    Citations:    Fields:    Translation:Humans
  9. Garnick MB. Testosterone replacement therapy faces FDA scrutiny. JAMA. 2015 Feb 10; 313(6):563-4. PMID: 25502018.
    Citations: 7     Fields:    Translation:Humans
  10. Garnick MB. Reply to S. Barni et Al and M. Sun et Al. J Clin Oncol. 2014 Nov 20; 32(33):3785. PMID: 25267752.
    Citations:    Fields:    Translation:Humans
  11. Garnick MB. How to interpret patient preferences in selecting the best drug: are the current measurements up to the job? J Clin Oncol. 2014 May 10; 32(14):1392-3. PMID: 24687838.
    Citations: 3     Fields:    Translation:Humans
  12. Garnick MB. Preserving the sanctity of overall survival for drugs approved on the basis of progression-free survival: tivozanib as a case study. J Clin Oncol. 2013 Oct 20; 31(30):3746-8. PMID: 24019543.
    Citations: 3     Fields:    Translation:Humans
  13. Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. 2013 Sep; 112(5):548-60. PMID: 23826876.
    Citations: 17     Fields:    Translation:Humans
  14. Garnick MB. More on confusion of drug names. N Engl J Med. 2013 05 16; 368(20):1947. PMID: 23675669.
    Citations:    Fields:    Translation:Humans
  15. Garnick MB. Possible confusion in names of new treatments for prostate cancer. N Engl J Med. 2013 Jan 10; 368(2):194. PMID: 23301754.
    Citations:    Fields:    Translation:Humans
  16. Garnick MB. Recommendations on use of prostate-specific antigen for prostate cancer screening. JAMA. 2012 Apr 04; 307(13):1372; author reply 1372-4. PMID: 22474197.
    Citations:    Fields:    Translation:HumansPHPublic Health
  17. Garnick MB. Editorial comment. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. BJU Int. 2012 Oct; 110(8):1155. PMID: 22369480.
    Citations:    Fields:    Translation:Humans
  18. Garnick MB. The great prostate cancer debate. Sci Am. 2012 Feb; 306(2):38-43. PMID: 22295676.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  19. Garnick MB. Ask the doctor. I take Avodart for my enlarged prostate. But I heard that Avodart increases prostate cancer risk. Is that true? Should I quit taking Avodart? Harv Health Lett. 2012 Jan; 37(3):8. PMID: 22400165.
    Citations:    Fields:    Translation:Humans
  20. Garnick MB, Mottet N. New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist. BJU Int. 2012 Aug; 110(4):499-504. PMID: 22093775.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  21. San Francisco IF, Werner L, Regan MM, Garnick MB, Bubley G, DeWolf WC. Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance. J Urol. 2011 Feb; 185(2):471-6. PMID: 21167525.
    Citations: 21     Fields:    Translation:Humans
  22. Garnick MB. Editorial comment. Urology. 2010 Jun; 75(6):1428-30; author reply 1430. PMID: 20513506.
    Citations:    Fields:    Translation:Humans
  23. Garnick MB. Screening and detection of breast cancer and prostate cancer. JAMA. 2010 Mar 17; 303(11):1033; author reply 1033-4. PMID: 20233818.
    Citations:    Fields:    Translation:HumansPHPublic Health
  24. Garnick MB. Important considerations in LHRH antagonist therapy for prostate cancer. Oncology (Williston Park). 2009 Jun; 23(7):636-7. PMID: 19626833.
    Citations:    Fields:    Translation:Humans
  25. Garnick MB. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data. J Clin Oncol. 2007 Oct 01; 25(28):4337-8. PMID: 17906195.
    Citations:    Fields:    Translation:Humans
  26. Debruyne F, Bhat G, Garnick MB. Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. Future Oncol. 2006 Dec; 2(6):677-96. PMID: 17155895.
    Citations: 11     Fields:    Translation:Humans
  27. Beer TM, Ryan C, Bhat G, Garnick M. Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study. Anticancer Drugs. 2006 Oct; 17(9):1075-9. PMID: 17001181.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  28. Ye M, Bhat G, Johnston KA, Tan H, Garnick M. Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules. Expert Opin Drug Deliv. 2006 Sep; 3(5):663-75. PMID: 16948561.
    Citations: 1     Fields:    
  29. Yannucci J, Manola J, Garnick MB, Bhat G, Bubley GJ. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters. J Urol. 2006 Aug; 176(2):520-5. PMID: 16813881.
    Citations: 17     Fields:    Translation:Humans
  30. Yannucci J, Manola J, Garnick M, Bubley G. The effect of androgen deprivation therapy (ADT) on lipid and HbA1C parameters. J Clin Oncol. 2005 Jun; 23(16_suppl):4562. PMID: 27946393.
    Citations:    
  31. Garnick MB, Pratt CM, Campion M, Shipley J. The effect of hormonal therapy for prostate cancer on the electrocardiographic QT interval: phase 3 results following treatment with leuprolide and goserelin, alone or with bicalutamide, and the GnRH antagonist abarelix. J Clin Oncol. 2004 Jul 15; 22(14_suppl):4578. PMID: 28015970.
    Citations:    
  32. Wong SL, Lau DT, Baughman SA, Fotheringham N, Menchaca D, Garnick MB. Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75. J Clin Pharmacol. 2004 May; 44(5):495-502. PMID: 15102870.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  33. Koch M, Steidle C, Brosman S, Centeno A, Gaylis F, Campion M, Garnick MB. An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists. Urology. 2003 Nov; 62(5):877-82. PMID: 14624912.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  34. Wong SL, Lau DT, Baughman SA, Menchaca D, Garnick MB. Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer. Clin Pharmacol Ther. 2003 Apr; 73(4):304-11. PMID: 12709720.
    Citations: 3     Fields:    Translation:Humans
  35. Trachtenberg J, Gittleman M, Steidle C, Barzell W, Friedel W, Pessis D, Fotheringham N, Campion M, Garnick MB. A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer. J Urol. 2002 Apr; 167(4):1670-4. PMID: 11912385.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  36. McLeod D, Zinner N, Tomera K, Gleason D, Fotheringham N, Campion M, Garnick MB. A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology. 2001 Nov; 58(5):756-61. PMID: 11711355.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  37. Tomera K, Gleason D, Gittelman M, Moseley W, Zinner N, Murdoch M, Menon M, Campion M, Garnick MB. The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. J Urol. 2001 May; 165(5):1585-9. PMID: 11342922.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  38. Joyal JL, Israel DI, Garnick MB. Comments on an in vitro model of hormonally refractory prostate cancer. Cancer J. 2000 Jul-Aug; 6(4):213-4. PMID: 11038139.
    Citations:    Fields:    Translation:AnimalsCells
  39. Garnick MB, Fair WR, Bostwick D, Debruyne F, Fourcroy J, Grignon D, Porterfield H, Sufrin G, Thrasher B, Hart C. Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Mol Urol. 2000; 4(3):89-92. PMID: 11184767.
    Citations:    Fields:    Translation:Humans
  40. Garnick MB, Campion M. Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group. Mol Urol. 2000; 4(3):275-7. PMID: 11062384.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  41. Ziada A, Crawford ED, Schröeder FH, Gleave ME, Miller PD, Garnick MB. Advanced prostate cancer: an update. Rev Urol. 2000; 2 Suppl 4:S35-9. PMID: 16986039.
    Citations:    
  42. Garnick MB. Disclosure statements regarding hormonal treatment of prostate cancer. N Engl J Med. 1999 May 27; 340(21):1689. PMID: 10348690.
    Citations:    Fields:    Translation:Humans
  43. Garnick MB. Hormonal treatment of prostate cancer. N Engl J Med. 1999 Mar 11; 340(10):812-3. PMID: 10075531.
    Citations:    Fields:    Translation:Humans
  44. Garnick MB. Hormonal Therapy in the Management of Prostate Cancer: An Historical Overview. Mol Urol. 1999; 3(3):175-182. PMID: 10851321.
    Citations: 2     Fields:    
  45. Garnick MB, Fair WR. Combating prostate cancer. Sci Am. 1998 Dec; 279(6):74-83. PMID: 9828467.
    Citations: 9     Fields:    Translation:Humans
  46. Morganstern D, Garnick MB. Genitourinary cancers in older adults. Clin Geriatr Med. 1998 May; 14(2):333-65. PMID: 9536109.
    Citations:    Fields:    Translation:Humans
  47. D'Amico AV, Chang E, Garnick M, Kantoff P, Jiroutek M, Tempany CM. Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology. 1998 Feb; 51(2):287-92. PMID: 9495713.
    Citations: 4     Fields:    Translation:Humans
  48. Crawford ED, Bennett CL, Stone NN, Knight SJ, DeAntoni E, Sharp L, Garnick MB, Porterfield HA. Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997 Sep; 50(3):366-72. PMID: 9301699.
    Citations: 19     Fields:    Translation:Humans
  49. Garnick MB. Hormonal therapy in the management of prostate cancer: from Huggins to the present. Urology. 1997 Mar; 49(3A Suppl):5-15. PMID: 9123737.
    Citations: 15     Fields:    Translation:Humans
  50. Garnick MB, Fair WR. First International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: overview consensus statement. Urology. 1997 Mar; 49(3A Suppl):1-4. PMID: 9123727.
    Citations: 1     Fields:    Translation:Humans
  51. Olumi AF, Garnick MB, Renshaw AA, Benson CA, Richie JP. Leydig cell hyperplasia mimicking testicular neoplasm. Urology. 1996 Oct; 48(4):647-9. PMID: 8886077.
    Citations:    Fields:    Translation:HumansCells
  52. Fair WR, Garnick MB. Neoadjuvant therapy prior to radical prostatectomy: pro. Urology. 1996 Oct; 48(4):535-8. PMID: 8886055.
    Citations:    Fields:    Translation:HumansAnimals
  53. Garnick MB, Fair WR. Prostate cancer: emerging concepts. Part II. Ann Intern Med. 1996 Aug 01; 125(3):205-12. PMID: 8686979.
    Citations: 2     Fields:    Translation:Humans
  54. Garnick MB, Fair WR. Prostate cancer: emerging concepts. Part I. Ann Intern Med. 1996 Jul 15; 125(2):118-25. PMID: 8678366.
    Citations: 5     Fields:    Translation:Humans
  55. Tepler I, Elias L, Smith JW, Hussein M, Rosen G, Chang AY, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood. 1996 May 01; 87(9):3607-14. PMID: 8611684.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  56. Jakubowski AA, Bajorin DF, Templeton MA, Chapman PB, Cody BV, Thaler H, Tao Y, Filippa DA, Williams L, Sherman ML, Garnick MB, Houghton AN. Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma. Clin Cancer Res. 1996 Feb; 2(2):295-302. PMID: 9816172.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  57. Garnick MB. The dilemmas of prostate cancer. Sci Am. 1994 Apr; 270(4):72-81. PMID: 8178117.
    Citations: 4     Fields:    Translation:Humans
  58. Garnick MB. Prostate cancer: screening, diagnosis, and management. Ann Intern Med. 1993 May 15; 118(10):804-18. PMID: 7682387.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  59. Rose RM, Kobzik L, Dushay K, Wolfthal S, Hondalus M, Metzger M, Stoudemire J, Brain JD, Garnick M, O'Donnell C, et al. The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis. 1992 Nov; 146(5 Pt 1):1279-86. PMID: 1443885.
    Citations: 7     Fields:    Translation:AnimalsCells
  60. Garnick MB. Tumors of the urinary tract. West J Med. 1992 May; 156(5):556. PMID: 18750877.
    Citations:    Fields:    
  61. Kantoff PW, Kalish LA, McDowell-Bryant P, Canellos GP, Gibbs R, Richie JP, Garnick MB. Long-term followup of 150 patients with testicular cancer treated at a single institution. J Urol. 1992 Jan; 147(1):82-8. PMID: 1370332.
    Citations:    Fields:    Translation:Humans
  62. Stomper PC, Kalish LA, Garnick MB, Richie JP, Kantoff PW. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology. 1991 Sep; 180(3):711-4. PMID: 1651526.
    Citations: 6     Fields:    Translation:Humans
  63. Stoudemire JB, Garnick MB. Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels. Blood. 1991 Feb 15; 77(4):750-5. PMID: 1993217.
    Citations: 9     Fields:    Translation:AnimalsCells
  64. Garnick MB, Abels R, Rudnick SA. The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome. Contrib Nephrol. 1991; 88:282-92; discussion 293-4. PMID: 2040191.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  65. VandePol CJ, Garnick MB. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF). Biotechnol Ther. 1991; 2(3-4):231-9. PMID: 1845128.
    Citations: 3     Fields:    Translation:Humans
  66. Soloway MS, Murphy WM, Johnson DE, Farrow GM, Paulson DF, Garnick MB. Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop. Br J Urol. 1990 Oct; 66(4):380-5. PMID: 2224432.
    Citations: 4     Fields:    Translation:Humans
  67. Johns WD, Garnick MB, Kaplan WD. Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan. Clin Nucl Med. 1990 Jul; 15(7):485-7. PMID: 2116949.
    Citations: 11     Fields:    Translation:Humans
  68. Munn DH, Garnick MB, Cheung NK. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood. 1990 May 15; 75(10):2042-8. PMID: 2186820.
    Citations: 14     Fields:    Translation:AnimalsCells
  69. Gillio AP, Gasparetto C, Laver J, Abboud M, Bonilla MA, Garnick MB, O'Reilly RJ. Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. J Clin Invest. 1990 May; 85(5):1560-5. PMID: 2332507.
    Citations: 2     Fields:    Translation:AnimalsCells
  70. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med. 1990 Apr 19; 322(16):1129-38. PMID: 2181313.
    Citations: 68     Fields:    Translation:Humans
  71. Ulich TR, del Castillo J, Watson LR, Yin SM, Garnick MB. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood. 1990 Feb 15; 75(4):846-50. PMID: 2405921.
    Citations: 13     Fields:    Translation:AnimalsCells
  72. Garnick MB, Stoudemire JB. Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF). Int J Cell Cloning. 1990 Jan; 8 Suppl 1:356-71; discussion 371-3. PMID: 2182744.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  73. Rieker PP, Fitzgerald EM, Kalish LA, Richie JP, Lederman GS, Edbril SD, Garnick MB. Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer. 1989 Dec 01; 64(11):2399-407. PMID: 2804933.
    Citations: 19     Fields:    Translation:Humans
  74. Garnick MB, O'Reilly RJ. Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6. Hematol Oncol Clin North Am. 1989 Sep; 3(3):495-509. PMID: 2698879.
    Citations: 1     Fields:    Translation:HumansAnimals
  75. Lederman GS, Herman TS, Jochelson M, Silver BJ, Chaffey JT, Garnick MB, Richie J, Sheldon TA, Coleman CN. Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy. Radiother Oncol. 1989 Mar; 14(3):203-8. PMID: 2710951.
    Citations: 2     Fields:    Translation:Humans
  76. Garnick MB. Testicular cancer. Semin Surg Oncol. 1989; 5(4):221-6. PMID: 2672228.
    Citations:    Fields:    Translation:Humans
  77. Talcott JA, Garnick MB, Stomper PC, Godleski JJ, Richie JP. Nodular pneumonitis after cancer chemotherapy. Ann Intern Med. 1989 Jan 01; 110(1):91. PMID: 2908836.
    Citations:    Fields:    Translation:Humans
  78. Garnick MB. Chemotherapy and bladder cancer. J Urol. 1989 Jan; 141(1):107. PMID: 2642307.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  79. Socinski MA, Garnick MB, Stomper PC, Fung CY, Richie JP. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low volume retroperitoneal disease. J Urol. 1988 Dec; 140(6):1437-41. PMID: 2848138.
    Citations: 3     Fields:    Translation:Humans
  80. Rogers LA, Longtine JA, Garnick MB, Pinkus GS. Silicone lymphadenopathy in a long distance runner: complication of a silastic prosthesis. Hum Pathol. 1988 Oct; 19(10):1237-9. PMID: 3169730.
    Citations: 2     Fields:    Translation:Humans
  81. Donahue RE, Seehra J, Metzger M, Lefebvre D, Rock B, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D, et al. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science. 1988 Sep 30; 241(4874):1820-3. PMID: 3051378.
    Citations: 28     Fields:    Translation:Animals
  82. Fung CY, Kalish LA, Brodsky GL, Richie JP, Garnick MB. Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J Clin Oncol. 1988 Sep; 6(9):1467-73. PMID: 2843611.
    Citations: 6     Fields:    Translation:Humans
  83. Kantoff PW, Garnick MB. Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer. J Clin Oncol. 1988 Aug; 6(8):1216-9. PMID: 2842462.
    Citations: 2     Fields:    Translation:Humans
  84. Morgentaler A, Garnick MB, Richie JP. Metastatic testicular teratoma invading the inferior vena cava. J Urol. 1988 Jul; 140(1):149-50. PMID: 3379682.
    Citations:    Fields:    Translation:HumansCells
  85. Garnick MB. Case 48-1987: pulmonary mass of 3 1/2 years' duration. N Engl J Med. 1988 Jun 02; 318(22):1467. PMID: 2835678.
    Citations:    Fields:    Translation:Humans
  86. Stomper PC, Socinski MA, Kaplan WD, Garnick MB. Failure patterns of nonseminomatous testicular germ cell tumors: radiographic analysis of 51 cases. Radiology. 1988 Jun; 167(3):641-6. PMID: 2452454.
    Citations:    Fields:    Translation:Humans
  87. Fung CY, Garnick MB. Clinical stage I carcinoma of the testis: a review. J Clin Oncol. 1988 Apr; 6(4):734-50. PMID: 3282036.
    Citations: 1     Fields:    Translation:Humans
  88. Socinski MA, Garnick MB. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med. 1988 Apr; 108(4):567-8. PMID: 2450502.
    Citations: 4     Fields:    Translation:Humans
  89. Garnick MB, Reich SD, Maxwell B, Coval-Goldsmith S, Richie JP, Rudnick SA. Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma. J Urol. 1988 Feb; 139(2):251-5. PMID: 3123714.
    Citations: 11     Fields:    Translation:Humans
  90. Swanson LJ, Seely JH, Garnick MB. Gonadotropin-releasing hormone analogs and prostatic cancer. Crit Rev Oncol Hematol. 1988; 8(1):1-26. PMID: 2964939.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  91. Kalish LA, Garnick MB, Richie JP. Appropriate endpoints for superficial bladder cancer clinical trials. J Clin Oncol. 1987 Dec; 5(12):2004-8. PMID: 3681382.
    Citations: 3     Fields:    Translation:Humans
  92. Stomper PC, Fung CY, Socinski MA, Jochelson MS, Garnick MB, Richie JP. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria. AJR Am J Roentgenol. 1987 Dec; 149(6):1187-90. PMID: 2825494.
    Citations: 1     Fields:    Translation:Humans
  93. Richie JP, Socinsky MA, Fung CY, Brodsky GL, Kalish LA, Garnick MB. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options. Arch Surg. 1987 Dec; 122(12):1443-5. PMID: 2446590.
    Citations:    Fields:    Translation:Humans
  94. Talcott JA, Garnick MB, Stomper PC, Godleski JJ, Richie JP. Cavitary lung nodules associated with combination chemotherapy containing bleomycin. J Urol. 1987 Sep; 138(3):619-20. PMID: 2442421.
    Citations:    Fields:    Translation:Humans
  95. Garnick MB. Current status of endocrine therapy for prostate cancer. Oncology (Williston Park). 1987 Sep; 1(7):19-25, 30-1, 34. PMID: 3079487.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  96. Lederman GS, Garnick MB. Pulmonary emboli as a complication of germ cell cancer treatment. J Urol. 1987 Jun; 137(6):1236-7. PMID: 3035237.
    Citations: 1     Fields:    Translation:Humans
  97. Licht JD, Garnick MB. Phase II trial of streptozocin in the treatment of advanced renal cell carcinoma. Cancer Treat Rep. 1987 Jan; 71(1):97-8. PMID: 2947680.
    Citations: 1     Fields:    Translation:Humans
  98. Lederman GS, Garnick MB. Possible benefit of doxorubicin treatment in patients with refractory germ cell cancer. Cancer. 1986 Dec 01; 58(11):2393-8. PMID: 2429755.
    Citations: 2     Fields:    Translation:Humans
  99. Garnick MB, Richie JP. Toward more rational management for stage I testis cancer: watch out for "watch and wait"! J Clin Oncol. 1986 Jul; 4(7):1021-3. PMID: 3723162.
    Citations:    Fields:    Translation:Humans
  100. Stomper PC, Jochelson MS, Friedman EL, Garnick MB, Richie JP. CT evaluation of advanced seminoma treated with chemotherapy. AJR Am J Roentgenol. 1986 Apr; 146(4):745-8. PMID: 3485347.
    Citations:    Fields:    Translation:Humans
  101. Garnick MB. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial. Urology. 1986 Jan; 27(1 Suppl):21-8. PMID: 3079935.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  102. Stomper PC, Jochelson MS, Garnick MB, Richie JP. Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology. AJR Am J Roentgenol. 1985 Oct; 145(4):743-6. PMID: 3875994.
    Citations: 4     Fields:    Translation:Humans
  103. Friedman EL, Garnick MB, Stomper PC, Mauch PM, Harrington DP, Richie JP. Therapeutic guidelines and results in advanced seminoma. J Clin Oncol. 1985 Oct; 3(10):1325-32. PMID: 2413180.
    Citations: 8     Fields:    Translation:Humans
  104. Rieker PP, Edbril SD, Garnick MB. Curative testis cancer therapy: psychosocial sequelae. J Clin Oncol. 1985 Aug; 3(8):1117-26. PMID: 4040551.
    Citations: 9     Fields:    Translation:Humans
  105. Andriole GL, Garnick MB, Richie JP. Unusual behavior of low-grade, low-stage transitional cell carcinoma of bladder. Urology. 1985 May; 25(5):524-6. PMID: 3992780.
    Citations: 1     Fields:    Translation:Humans
  106. Nichols CR, Hoffman R, Einhorn LH, Williams SD, Wheeler LA, Garnick MB. Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med. 1985 May; 102(5):603-9. PMID: 2984971.
    Citations: 25     Fields:    Translation:Humans
  107. Garnick MB, Glode LM, Smith JA, Max DT. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate. Br J Clin Pract Suppl. 1985 Mar; 37:8-12, 20-4. PMID: 3931665.
    Citations:    Fields:    Translation:Humans
  108. Garnick MB. Advanced testicular cancer: treatment choices in the "land of plenty". J Clin Oncol. 1985 Mar; 3(3):294-7. PMID: 2579211.
    Citations: 4     Fields:    Translation:Humans
  109. Garnick MB, Glode LM, Smith JA, Max DT. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate. Br J Clin Pract. 1985 Feb; 39(2):73-6. PMID: 3921047.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  110. Kaplan WD, Come SE, Takvorian RW, Laffin SM, Gelman RS, Weiss GR, Garnick MB. Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol. 1984 Nov; 2(11):1266-9. PMID: 6491704.
    Citations: 2     Fields:    Translation:Humans
  111. Garnick MB, Ernst T, Martinez F. Acute febrile reaction to streptozocin. N Engl J Med. 1984 Sep 20; 311(12):798. PMID: 6236370.
    Citations:    Fields:    Translation:Humans
  112. Jochelson MS, Garnick MB, Balikian JP, Richie JP. The efficacy of routine whole lung tomography in germ cell tumors. Cancer. 1984 Sep 15; 54(6):1007-9. PMID: 6088015.
    Citations: 1     Fields:    Translation:Humans
  113. Goldberg ID, Garnick MB, Bloomer WD. Urinary tract toxic effects of cancer therapy. J Urol. 1984 Jul; 132(1):1-6. PMID: 6233430.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  114. Richie JP, Garnick MB. Changing concepts in the treatment of nonseminomatous germ cell tumors of the testis. J Urol. 1984 Jun; 131(6):1089-92. PMID: 6202888.
    Citations: 1     Fields:    Translation:Humans
  115. Andriole GL, Bettmann MA, Garnick MB, Richie JP. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J Urol. 1984 Feb; 131(2):239-41. PMID: 6699952.
    Citations: 8     Fields:    Translation:Humans
  116. Garnick MB, Schade D, Israel M, Maxwell B, Richie JP. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol. 1984 Jan; 131(1):43-6. PMID: 6690745.
    Citations: 10     Fields:    Translation:Humans
  117. Lederman GS, Garnick MB, Canellos GP, Richie JP. Chemotherapy of refractory germ cell cancer with Etoposide. J Clin Oncol. 1983 Nov; 1(11):706-9. PMID: 6321675.
    Citations: 3     Fields:    Translation:Humans
  118. Garnick MB, Canellos GP, Richie JP. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA. 1983 Oct 07; 250(13):1733-41. PMID: 6684188.
    Citations: 8     Fields:    Translation:Humans
  119. Karp GI, von Oeyen P, Valone F, Khetarpal VK, Israel M, Mayer RJ, Frigoletto FD, Garnick MB. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983 Sep; 67(9):773-7. PMID: 6883353.
    Citations: 12     Fields:    Translation:Humans
  120. Garnick MB. Oral metoclopramide and cisplatin chemotherapy. Ann Intern Med. 1983 Jul; 99(1):127. PMID: 6683089.
    Citations: 1     Fields:    Translation:Humans
  121. Garnick MB, Griffin JD. Idiopathic thrombocytopenia in association with extragonadal germ cell cancer. Ann Intern Med. 1983 Jun; 98(6):926-7. PMID: 6305246.
    Citations: 4     Fields:    Translation:Humans
  122. Richie JP, Garnick MB, Seltzer S, Bettmann MA. Computerized tomography scan for diagnosis and staging of renal cell carcinoma. J Urol. 1983 Jun; 129(6):1114-6. PMID: 6854781.
    Citations: 1     Fields:    Translation:Humans
  123. Weiss GR, Garnick MB, Osteen RT, Steele GD, Wilson RE, Schade D, Kaplan WD, Boxt LM, Kandarpa K, Mayer RJ, et al. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol. 1983 May; 1(5):337-44. PMID: 6199474.
    Citations: 11     Fields:    Translation:Humans
  124. Anderson KC, Garnick MB, Meshad MW, Cohen GI, Pegg WJ, Frei E, Israel M, Modest E, Canellos GP. Phase I trial of mitoxantrone by 24-hour continuous infusion. Cancer Treat Rep. 1983 May; 67(5):435-8. PMID: 6850662.
    Citations: 1     Fields:    Translation:Humans
  125. Bauer KA, Skarin AT, Balikian JP, Garnick MB, Rosenthal DS, Canellos GP. Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med. 1983 Apr; 74(4):557-63. PMID: 6188377.
    Citations: 9     Fields:    Translation:Humans
  126. Kaplan WD, Garnick MB, Richie JP. Iliopelvic radionuclide lymphoscintigraphy in patients with testicular cancer. Radiology. 1983 Apr; 147(1):231-5. PMID: 6828735.
    Citations: 1     Fields:    Translation:Humans
  127. Li FP, Little JB, Bech-Hansen NT, Paterson MC, Arlett C, Garnick MB, Mayer RJ. Acute leukemia after radiotherapy in a patient with Turcot's syndrome. Impaired colony formation in skin fibroblast cultures after irradiation. Am J Med. 1983 Feb; 74(2):343-8. PMID: 6572034.
    Citations: 3     Fields:    Translation:HumansCells
  128. Garnick MB, Weiss GR, Steele GD, Israel M, Schade D, Sack MJ, Frei E. Clinical evaluation of long-term, continuous-infusion doxorubicin. Cancer Treat Rep. 1983 Feb; 67(2):133-42. PMID: 6825120.
    Citations: 9     Fields:    Translation:HumansAnimals
  129. Kaplan MM, Garnick MB, Gelber R, Li FP, Cassady JR, Sallan SE, Fine WE, Sack MJ. Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med. 1983 Feb; 74(2):272-80. PMID: 6824006.
    Citations: 5     Fields:    Translation:Humans
  130. Robert NJ, Garnick MB, Frei E. Cancers of unknown origin: current approaches and future perspectives. Semin Oncol. 1982 Dec; 9(4):526-31. PMID: 6189190.
    Citations: 2     Fields:    Translation:Humans
  131. Fram RJ, Garnick MB, Retik A. The spectrum of genitourinary abnormalities in patients with cryptorchidism, with emphasis on testicular carcinoma. Cancer. 1982 Nov 15; 50(10):2243-6. PMID: 6127155.
    Citations: 2     Fields:    Translation:Humans
  132. Anderson KC, Cohen GI, Garnick MB. Phase II trial of mitoxantrone. Cancer Treat Rep. 1982 Nov; 66(11):1929-31. PMID: 7139638.
    Citations: 2     Fields:    Translation:Humans
  133. Hickey WF, Garnick MB, Henderson IC, Dawson DM. Primary cerebral venous thrombosis in patients with cancer--a rarely diagnosed paraneoplastic syndrome. Report of three cases and review of the literature. Am J Med. 1982 Nov; 73(5):740-50. PMID: 6753578.
    Citations: 3     Fields:    Translation:Humans
  134. Balikian JP, Jochelson MS, Bauer KA, Skarkin AT, Garnick MB, Canellos GP, Smith EH. Pulmonary complications of chemotherapy regimens containing bleomycin. AJR Am J Roentgenol. 1982 Sep; 139(3):455-61. PMID: 6180618.
    Citations: 5     Fields:    Translation:Humans
  135. Todd RF, Garnick MB, Canellos GP. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma. Cancer Treat Rep. 1982 Jul; 66(7):1585-6. PMID: 7093973.
    Citations: 1     Fields:    Translation:Humans
  136. Richie JP, Birnholz J, Garnick MB. Ultrasonography as a diagnostic adjunct for the evaluation of masses in the scrotum. Surg Gynecol Obstet. 1982 May; 154(5):695-8. PMID: 7071705.
    Citations: 1     Fields:    Translation:Humans
  137. Waters WB, Garnick MB, Richie JP. Complications of retroperitoneal lymphadenectomy in the management of nonseminomatous tumors of the testis. Surg Gynecol Obstet. 1982 Apr; 154(4):501-4. PMID: 7064080.
    Citations:    Fields:    Translation:Humans
  138. Richie JP, Garnick MB, Finberg H. Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol. 1982 Apr; 127(4):715-7. PMID: 7069838.
    Citations: 9     Fields:    Translation:Humans
  139. Weiss GR, Garnick MB. Testicular cancer in a Russell-Silver dwarf. J Urol. 1981 Dec; 126(6):836-7. PMID: 6119370.
    Citations: 6     Fields:    Translation:Humans
  140. Griffin JD, Garnick MB. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer. 1981 Oct 01; 48(7):1539-49. PMID: 7026021.
    Citations: 10     Fields:    Translation:Humans
  141. Herrmann VM, Garnick MB, Moore FD, Wilmore DW. Effect of cytotoxic agents on protein kinetics in patients with metastatic cancer. Surgery. 1981 Aug; 90(2):381-7. PMID: 6166997.
    Citations: 4     Fields:    Translation:Humans
  142. Blum RH, Garnick MB, Israel M, Panellos GP, Henderson IC, Frei E. Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32. Recent Results Cancer Res. 1981; 76:7-15. PMID: 7232854.
    Citations: 7     Fields:    Translation:HumansAnimals
  143. Todd RF, Garnick MB, Canellos GP, Richie JP, Gittes RF, Mayer RJ, Skarin AT. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):17-20. PMID: 7226167.
    Citations: 1     Fields:    Translation:Humans
  144. Frei E, Garnick MB, Ensminger WD, Israel M, Steele GD, Kaplan WD, Come SE. Biochemical pharmacology in medical oncology. Cancer Treat Rep. 1981; 65 Suppl 3:21-6. PMID: 6213298.
    Citations: 2     Fields:    Translation:Humans
  145. Garnick MB. Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer. N Engl J Med. 1980 Nov 13; 303(20):1177. PMID: 7421935.
    Citations: 3     Fields:    Translation:HumansAnimals
  146. Frei E, Blum RH, Pitman SW, Kirkwood JM, Henderson IC, Skarin AT, Mayer RJ, Bast RC, Garnick MB, Parker LM, Canellos GP. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med. 1980 Mar; 68(3):370-6. PMID: 6965819.
    Citations: 22     Fields:    Translation:Humans
  147. Garnick MB, Mayer RJ, Richie JP. Testicular self-examination. N Engl J Med. 1980 Jan 31; 302(5):297. PMID: 7350489.
    Citations: 2     Fields:    Translation:Humans
  148. Todd RF, Garnick MB. Prostatic adenocarcinoma, sarcoidosis and hypercalcemia: an unusual association. J Urol. 1980 Jan; 123(1):133-4. PMID: 7351709.
    Citations: 2     Fields:    Translation:Humans
  149. Garnick MB, Blum RH, Canellos GP, Mayer RJ, Parker L, Skarin AT, Li FP, Henderson IC, Frei E. Phase I trial of bruceantin. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1929-32. PMID: 526926.
    Citations: 4     Fields:    Translation:Humans
  150. Garnick MB, Ensminger WD, Israel M. A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin. Cancer Res. 1979 Oct; 39(10):4105-10. PMID: 476647.
    Citations: 18     Fields:    Translation:Humans
  151. Garnick MB, Canellos GP, Richie JP, Stark JJ. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin. Cancer Treat Rep. 1979 Sep-Oct; 63(9-10):1681-6. PMID: 91438.
    Citations: 2     Fields:    Translation:Humans
  152. Garnick MB, Larsen PR. Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy. N Engl J Med. 1979 Aug 02; 301(5):252-3. PMID: 109764.
    Citations: 5     Fields:    Translation:HumansCells
  153. Garnick MB, Skarin AT, Steele GD. Metastatic carcinoma of the penis: complete remission after high dose methotrexate chemotherapy. J Urol. 1979 Aug; 122(2):265-6. PMID: 313458.
    Citations: 2     Fields:    Translation:Humans
  154. Blum RH, Garnick MB, Israel M, Canellos GP, Henderson IC, Frei E. Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog. Cancer Treat Rep. 1979 May; 63(5):919-23. PMID: 455334.
    Citations: 7     Fields:    Translation:Humans
  155. Lokich JJ, Garnick MB, Legg M. Intralesional immune therapy: methanol extraction residue of BCG or purified protein derivative. Oncology. 1979; 36(5):236-41. PMID: 481845.
    Citations: 2     Fields:    Translation:Humans
  156. Garnick MB, Bennett PH, Langer T. Low density lipoprotein metabolism and lipoprotein cholesterol content in southwestern American Indians. J Lipid Res. 1979 Jan; 20(1):31-. PMID: 220352.
    Citations: 4     Fields:    Translation:Humans
  157. Mirel RD, Garnick MB. Skin tests, penicillin G procaine, and pseudoanaphylaxis. JAMA. 1978 Oct 13; 240(16):1751-2. PMID: 691178.
    Citations:    Fields:    Translation:Humans
  158. Mayer RJ, Garnick MB, Steele GD, Zamcheck N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer. 1978 Sep; 42(3 Suppl):1428-33. PMID: 709511.
    Citations: 15     Fields:    Translation:Humans
  159. Bennion LJ, Drobny E, Knowler WC, Ginsberg RL, Garnick MB, Adler RD, Duane WC. Sex differences in the size of bile acid pools. Metabolism. 1978 Aug; 27(8):961-9. PMID: 672615.
    Citations: 10     Fields:    Translation:Humans
  160. Garnick MB, Mayer RJ. Acute renal failure associated with neoplastic disease and its treatment. Semin Oncol. 1978 Jun; 5(2):155-65. PMID: 150033.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  161. Garnick M, Lokich JJ. Primary malignant melanoma of the rectum: rationale for conservative surgical management. J Surg Oncol. 1978; 10(6):529-31. PMID: 83453.
    Citations: 3     Fields:    Translation:Humans
  162. Ginsberg RL, Garnick MB. Effect of phenobarbital on biliary lipid metabolism in normal man. Gastroenterology. 1977 Jun; 72(6):1221-7. PMID: 870370.
    Citations: 2     Fields:    Translation:Humans
  163. Bennion LJ, Ginsberg RL, Garnick MB, Bennett PH. Letter: Effects of the normal menstrual cycle on human gallbladder bile. N Engl J Med. 1976 05 20; 294(21):1187-8. PMID: 1264129.
    Citations: 4     Fields:    Translation:Humans
  164. Bennion LJ, Ginsberg RL, Garnick MB, Bennett PH. Letter: Effects of the normal menstrual cycle on human gallbladder bile. N Engl J Med. 1976 Feb 5; 294(6):348. PMID: 1246287.
    Citations:    
  165. Garnick MB. Letter: "Hot-watch syndrome". N Engl J Med. 1976 Jan 01; 294(1):54. PMID: 1244477.
    Citations:    Fields:    Translation:HumansPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Garnick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (481)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.